Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PLAUR Antibody (Center) [APR06076G] | Login | PLAUR Antibody (Center) [APR06076G] | ||||||||||||||||
|
||||||||||||||||||
| PIK3CG Antibody (C-term) [APR06080G] | Login | PIK3CG Antibody (C-term) [APR06080G] | ||||||||||||||||
|
||||||||||||||||||
| PIK3CG Antibody (S1100) [APR06081G] | Login | PIK3CG Antibody (S1100) [APR06081G] | ||||||||||||||||
|
||||||||||||||||||
| BMI1 Antibody [APR06119G] | Login | BMI1 Antibody [APR06119G] | ||||||||||||||||
|
||||||||||||||||||
| TOP2A Antibody (C-term) [APR06153G] | Login | TOP2A Antibody (C-term) [APR06153G] | ||||||||||||||||
|
||||||||||||||||||
| P21Cip1 Antibody [APR06159G] | Login | P21Cip1 Antibody [APR06159G] | ||||||||||||||||
|
||||||||||||||||||
| IL2RG Antibody (N-term) [APR06171G] | Login | IL2RG Antibody (N-term) [APR06171G] | ||||||||||||||||
|
||||||||||||||||||
| IL2RG Antibody (Center) [APR06172G] | Login | IL2RG Antibody (Center) [APR06172G] | ||||||||||||||||
|
||||||||||||||||||
| HLA-DRB5 Antibody (Center) [APR06202G] | Login | HLA-DRB5 Antibody (Center) [APR06202G] | ||||||||||||||||
|
||||||||||||||||||
| HLA-DRB1 Antibody (N-term) [APR05816G] | Login | HLA-DRB1 Antibody (N-term) [APR05816G] | ||||||||||||||||
|
||||||||||||||||||
| GAB2 Antibody (N-term) [APR05817G] | Login | GAB2 Antibody (N-term) [APR05817G] | ||||||||||||||||
|
||||||||||||||||||
| CAMKK2 Antibody (C-term) [APR05845G] | Login | CAMKK2 Antibody (C-term) [APR05845G] | ||||||||||||||||
|
||||||||||||||||||
| Cyclin A (CCNA2) Antibody (N-term) [APR05876G] | Login | Cyclin A (CCNA2) Antibody (N-term) [APR05876G] | ||||||||||||||||
|
||||||||||||||||||
| S100A6 Antibody (C-term) [APR05894G] | Login | S100A6 Antibody (C-term) [APR05894G] | ||||||||||||||||
|
||||||||||||||||||
| MYCN Antibody (C-term) [APR05903G] | Login | MYCN Antibody (C-term) [APR05903G] | ||||||||||||||||
|
||||||||||||||||||
| CHK1 Antibody (C-term) [APR05904G] | Login | CHK1 Antibody (C-term) [APR05904G] | ||||||||||||||||
|
||||||||||||||||||
| Vinculin Antibody (C-term) [APR05907G] | Login | Vinculin Antibody (C-term) [APR05907G] | ||||||||||||||||
|
||||||||||||||||||
| GTSE1 Antibody (C-term) [APR06209G] | Login | GTSE1 Antibody (C-term) [APR06209G] | ||||||||||||||||
|
||||||||||||||||||
| Bcl-2 Antibody (BH3 Domain Specific) [APR06977G] | Login | Bcl-2 Antibody (BH3 Domain Specific) [APR06977G] | ||||||||||||||||
|
||||||||||||||||||
| FDPS Antibody (Center) [APR06992G] | Login | FDPS Antibody (Center) [APR06992G] | ||||||||||||||||
|
||||||||||||||||||
| mTOR (FRAP1) Antibody (S2481) [APR07003G] | Login | mTOR (FRAP1) Antibody (S2481) [APR07003G] | ||||||||||||||||
|
||||||||||||||||||
| NAMPT Antibody (Center) [APR07016G] | Login | NAMPT Antibody (Center) [APR07016G] | ||||||||||||||||
|
||||||||||||||||||
| cIAP2 (BIRC3) Antibody (N-term) [APR07031G] | Login | cIAP2 (BIRC3) Antibody (N-term) [APR07031G] | ||||||||||||||||
|
||||||||||||||||||
| SMAD3-S208 Antibody [APR07042G] | Login | SMAD3-S208 Antibody [APR07042G] | ||||||||||||||||
|
||||||||||||||||||
| AMPK alpha 1 Antibody (C-term) [APR07059G] | Login | AMPK alpha 1 Antibody (C-term) [APR07059G] | ||||||||||||||||
|
||||||||||||||||||


